Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Biomolecules
|
December 30, 2025
The PELP1 Pathway and Its Importance in Cancer Treatment
Khaled Mohamed Nassar, Panneerdoss Subbarayalu, Suryavathi Viswanadhapalli, et al.
Cells
|
May 13, 2023
The RNA Demethylase ALKBH5 Maintains Endoplasmic Reticulum Homeostasis by Regulating UPR, Autophagy, and Mitochondrial Function
Panneerdoss Subbarayalu, Pooja Yadav, Santosh Timilsina, et al.
Cancer Letters
|
May 14, 2022
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
Santosh Timilsina, Subapriya Rajamanickam, Arhan Rao, et al.
Oncotarget
|
November 22, 2017
Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die
Benjamin Onyeagucha, Panneerdoss Subbarayalu, Nourhan Abdelfattah, et al.
Endocrinology
|
December 13, 2021
Concordant Androgen-Regulated Expression of Divergent Rhox5 Promoters in Sertoli Cells
Anjana Bhardwaj, Abhishek Sohni, Chih-Hong Lou, et al.
Cancers
|
March 13, 2025
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
Bianca Romo, Zenaida Fuentes, Lois Randolph, et al.
Cancers
|
November 9, 2024
Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer
Lois Randolph, Jaitri Joshi, Alondra Lee Rodriguez Sanchez, et al.
Cancer Research
|
March 18, 2022
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression
Pooja Yadav, Panneerdoss Subbarayalu, Daisy Medina, et al.
Molecular Cancer Therapeutics
|
April 30, 2025
The discovery and characterization of HBS-101, a novel inhibitor of midkine, as a therapeutic agent for the treatment of triple negative breast cancer
Megharani Mahajan, Alondra L Rodriguez Sanchez, Sridharan Jayamohan, et al.
International Journal of Molecular Sciences
|
December 23, 2023
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Biomolecules
|
December 30, 2025
The PELP1 Pathway and Its Importance in Cancer Treatment
Khaled Mohamed Nassar, Panneerdoss Subbarayalu, Suryavathi Viswanadhapalli, et al.
Cells
|
May 13, 2023
The RNA Demethylase ALKBH5 Maintains Endoplasmic Reticulum Homeostasis by Regulating UPR, Autophagy, and Mitochondrial Function
Panneerdoss Subbarayalu, Pooja Yadav, Santosh Timilsina, et al.
Cancer Letters
|
May 14, 2022
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
Santosh Timilsina, Subapriya Rajamanickam, Arhan Rao, et al.
Oncotarget
|
November 22, 2017
Novel post-transcriptional and post-translational regulation of pro-apoptotic protein BOK and anti-apoptotic protein Mcl-1 determine the fate of breast cancer cells to survive or die
Benjamin Onyeagucha, Panneerdoss Subbarayalu, Nourhan Abdelfattah, et al.
Endocrinology
|
December 13, 2021
Concordant Androgen-Regulated Expression of Divergent Rhox5 Promoters in Sertoli Cells
Anjana Bhardwaj, Abhishek Sohni, Chih-Hong Lou, et al.
Cancers
|
March 13, 2025
Targeting the Leukemia Inhibitory Factor/Leukemia Inhibitory Factor Receptor Axis Reduces the Growth of Inflammatory Breast Cancer by Promoting Ferroptosis
Bianca Romo, Zenaida Fuentes, Lois Randolph, et al.
Cancers
|
November 9, 2024
Significance of LIF/LIFR Signaling in the Progression of Obesity-Driven Triple-Negative Breast Cancer
Lois Randolph, Jaitri Joshi, Alondra Lee Rodriguez Sanchez, et al.
Cancer Research
|
March 18, 2022
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression
Pooja Yadav, Panneerdoss Subbarayalu, Daisy Medina, et al.
Molecular Cancer Therapeutics
|
April 30, 2025
The discovery and characterization of HBS-101, a novel inhibitor of midkine, as a therapeutic agent for the treatment of triple negative breast cancer
Megharani Mahajan, Alondra L Rodriguez Sanchez, Sridharan Jayamohan, et al.
International Journal of Molecular Sciences
|
December 23, 2023
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling
Nicole Spencer, Alondra Lee Rodriguez Sanchez, Rahul Gopalam, et al.
Page
of 2